Summary
Becton, Dickinson and Company (BD) filed an 8-K on April 2, 2026, to provide investors with updated financial information following the spin-off and combination of its Biosciences and Diagnostic Solutions business with Waters Corporation, which was completed on February 9, 2026. The company has furnished recast historical financial information to present its standalone operating results from continuing operations, effectively treating the divested business segment as discontinued operations. This filing is crucial for investors to understand BD's performance and financial condition on a go-forward basis, separate from the divested segment. The provided recast financial information includes non-GAAP measures, and investors are advised to review the accompanying schedules within Exhibit 99.1 for detailed explanations of these adjustments and their impact on the reported figures. This information is furnished and not deemed 'filed' for regulatory purposes.
Key Highlights
- 1BD has provided recast historical financial information to reflect its standalone operations post-spin-off.
- 2The spin-off and combination of the Biosciences and Diagnostic Solutions business with Waters Corporation was completed on February 9, 2026.
- 3The recast financials present the divested segment as discontinued operations.
- 4This information aims to provide investors with a clearer view of BD's continuing operations.
- 5The filing includes non-GAAP financial measures, with detailed reconciliations available in Exhibit 99.1.
- 6The furnished information is not considered 'filed' for the purposes of Section 18 of the Exchange Act.